x
ServiziMenu principaleHome
You are here: Home > Educational Opportunities > Past events > 2013 > 2nd ESO-ESSO Masterclass in Colorectal Cancer Surgery
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

2nd ESO-ESSO Masterclass in Colorectal Cancer Surgery

30 ESCO credits

23.02.2013  -  28.02.2013

Ljubljana, Slovenia

MASTERCLASS

Colon/colorectal cancer

Description

Chairs: T. Wiggers, NL - L. Påhlman, SE - K. Havenga, NL


AIMS AND OBJECTIVES
Based on the knowledge of total mesocolon and total mesorectal surgey and imaging before the operation, after the Masterclass participants will be able to answer the 10 following questions:

• Is screening to be implemented?
• How does staging influence clinical decision making?
• Which information may influence treatment choices?
• Where do I damage the autonomic nerve plexus?
• How and when can I minimize the procedure?
• How do I position the patient for the perineal phase and perform a wide excision for low rectal cancers?
• How do I deal with the loss of a pelvic floor after a wide perineal resection and how do I correct a perineal hernia?
• How do I estimate the ned of a defunctioning colostomy and how do treat leakage of the anastomosis?
• How do treat a patient with colorectal cancer and synchronous liver metastases?
• How do I balance the advantages and disadvantages of adjuvant treatment (numbers needed to treat)?


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages.
Workshop Sessions in small groups will be organised in areas of decision making in complex cases.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and faculty.
All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.


THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts will contribute to the programme

General information

FOR FURTHER INFORMATION PLEASE CONTACT:
Carine Lecoq
Society Co-ordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83 - B-1200 Brussels
Tel: +32 2 537 31 06
Fax: +32 2 539 03 74
e-mail:
info@essoweb.org
url: www.essoweb.org


PARTICIPATION
Attendance is limited to 40 participants and admittance is by competitive application only. The successful of applicants are granted free registration but a contribution to the costs of full-board accommodation at the course venue (EUR 600 for ESSO/ESO club members and EUR 700 for non-members) travel and one free dinner are to be covered by the participants.


ACCREDITATION
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Following accreditation approval by ACOE  this event has been granted European endorsement by the UEMS and awarded 27 European Continuing Medical Education Credits (ECMEC).
  


Faculty list


FACULTY (as of November)
G. Baatrup, Haukeland University Hospital, Department of Surgery, Section of Colorectal Surgery, Bergen, NO
H. Becker, Geog-August-University, Department of General Surgery, Göttingen, DE
G. Beets, Academic Hospital Maastricht, Department of Surgery, Maastricht, NL
M. de Ruiter, Leiden University Medical Center, Department of Anatomy and Embryology, Leiden, NL
I. Edhemovic, Institute of Oncology, Dept. of Surgery, Ljubljana, SI
O. Glehen, Centre Hospitalier Lyon Sud, Dept. of Surgical Oncology, Pierre Bénite, FR
K. Havenga, University Medical Centre Groningen, Department of Surgery, Groningen, NL
T. Holm, Karolinska University Hospital, Department of Surgery, Stockholm, SE
K. Homayounfar, Universitätsmedizin Göttingen, Georg-August-Universität, Klinik für Allgemein- und Viszeralchirurgie, Göttingen, DE
A. Lindblom, Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, SE
L. Påhlman, University Hospital Uppsala, Department of Surgical Sciences, Section of Surgery, Uppsala, SE
P. Pfeiffer, Odense University Hospital, Institute of Clinical Research, Dept. of Oncology, Odense, DK
G.J. Poston, Aintree University Hospital, Department of Surgery, Liverpool, UK
N. Scott, St. James’s University Hospital, Department of Histopathology, Leeds, UK
P. Tekkis, The Royal Marsden Hospital, Department of Surgery, St. Mary’s NHS Trust, London, UK
E. Tiret, Saint-Antoine Hospital, Centre for Digestive Surgery, Paris, FR
V. Valentini, Cattedra di Radioterapia - Istituto di Radiologia, Policlinico Gemelli Università Cattolica S. Cuore, Rome, IT
T. Wiggers, University Medical Centre Groningen, Department of Surgery, Groningen, NL

Programme


23 February

 

Arrival and airport transfers

   16:00

Registration

   20:00

Aperitif and Welcome dinner 

 

24 February

 8:30Lecture The history of colorectal cancer surgery  
T. Wiggers, NL
 9:00Workshop sessions, participants will rotate among:
 
  • Staging of rectal cancer as an example in oncology  
    T. Wiggers, NL
  • Cadaver demonstration: Compartments, spaces and pelvic floor (video) 
    M. de Ruiter, NL
  • Cadaver demonstration: Autonomic nerves: Seven times at risk (video) K. Havenga, NL
  • MR Imaging of rectal cancer
    G. Beets, NL

 10:40

Coffee break

 11:10

Workshop sessions, continuation

 12:50

Lunch

 14:00

Symposium Factors influencing decision making
Chair: L. Påhlman, SE 

 

  • Genetic syndrome, FAP, Lynch    
    A. Lindblom, SE 
  • Age and co-morbidity and frailty     
    T. Wiggers, NL
  • Staging by high-quality imaging
    G. Beets, NL

 15:30

Coffee break

 16:00

Lecture Genetic and epigenetic analysis of sporadic colon cancer: Decision and treatment
A. Lindblom, SE

 16:30

Group sessions Case presentations by the participants
Group 1 (G. Baatrup, NO) - Group 2 (K. Havenga, NL) - Group 3 (L. Påhlman, SE) - Group 4 (T. Holm, SE) 

 19:00

Dinner 

 

25 February

   8:30

Lecture Pathology: CRM and regression after chemoradiation 
N. Scott, UK

   9:00

Workshop sessions, participants will rotate among:

 

  • Endoluminal ultrasound     
    G. Baatrup, NO
  • Positioning and technique of a wide perineal resection  
    T. Holm, SE
  • Filling, reconstruction and perineal hernia's   
    K. Havenga, NL
  • Stoma's: Colostomy, ileostomy. Timing of closure
    G. Beets, NL 

 10:40

Coffee break

 11:10Workshop sessions, continuation
 12:50Lunch 
 14:00Symposium Is less possible?
Chair: P. Tekkis, UK
 14:00Advanced Rectal Cancer     
P. Tekkis, UK

 14:30

Ultralow resections     
E. Tiret, FR

 15:00

Laparoscopic resections     
P. Tekkis, UK

 15:30

Coffee break 

 16:00

Lecture Response after chemoradiation on imaging   
G. Beets, NL

 16:30Group sessions Case presentations by the participants (participants play the role of representatives of different disciplines) 
Group 1 (E. Tiret, FR) - Group 2 (I. Edhemovic, SI) - Group 3 (L. Påhlman, SE) - Group 4 (K. Havenga, NL)

 18:30

Transfer to Ljubljana and free dinner 

 

26 February

  8:30

Lecture Fields, beams and schedules in radiation oncology 
V. Valentini, IT

  9:00

Workshop sessions

 

  • Stapling techniques     
    K. Havenga, NL
  • Screening for colorectal cancer      
    L. Påhlman, SE
  • Early detection and treatment of leakage   
    T. Holm, SE
  • Localization of non palpable lesions during operation
    I. Edhemovic, SI  

The four groups of participants will rotate among the workshop sessions which last 50 minutes.

  9:00

First round 

  9:50

Second round 
 10:40Coffee break 
 11:00Third round 
 11:50Fourth round 

 12:50

Lunch
 14:00Lecture Quality of life after surgery         
E. Tiret, FR
 

 14:30

Symposium Quality and organisation of care 
Chair: I. Edhemovic, SI

 
  • Follow-up: Evidence and optimalisation  
    K. Havenga, NL
  • The colorectal audit    
    T. Wiggers, NL
  • Coffee break (15:30)
  • Value of a multidisciplinary team   
    O. Glehen, FR

 16:30

Group sessions Case presentations by the participants
Group 1 (O. Glehen, FR) - Group 2 (I. Edhemovic, SI) - Group 3 (V. Valentini, IT) - Group 4 (T. Holm, SE)   
 19:00Dinner 

 

27 February

 8:30Lecture Systematic review and meta-analyses  
T. Wiggers, NL
 9:00Symposium Numbers needed to treat: Neoadjuvant radiation therapy
Lecture and clinical debate by the participants with comments of experts
Chair: L. Påhlman, SE

 

  • Is indicated in (almost all cases)   
    Selected participant
  • Presents with major morbidity   
    Selected participant

 10:00

Discussion with the experts     
V. Valentini, IT - P. Tekkis, UK

 10:30

Coffee break 

 11:00

Symposium Numbers needed to treat: Adjuvant chemotherapy in rectal cancer
Lectures and clinical debate by the participants with comments of the experts    
Chair: L. Påhlman, SE  

 

  • Should be offered like in colon cancer  
    Selected participant
  • Is not proven to be efficacious   
    Selected participant

 12:30

Discussion with the experts:     
V. Valentini, IT - H. Becker, DE

 13:00

Lunch

 14:00

Symposium Advanced cases    
Chair: K. Havenga, NL

 
  • HIPEC in carcinomatosis      
    O. Glehen, FR
  • Indications for transanal endoscopic microsurgery    
    G. Baatrup, NO
  • Liver surgery after neo-adjuvant chemotherapy  
    G. Poston, UK

 15:30

Coffee break 

 16:00

Lecture Rtotal mesorectal excision (TME) complete mesocolic excision (ME) 
K. Homayounfar

 16:3018:00

Group sessions Case presentations by the participants 
Group 1 (G. Poston, UK) - Group 2 (K. Homayounfar) - Group 3 (V. Valentini, IT) - Group 4 (T. Wiggers, NL)

 19:00

Dinner

 

28 February

  8:30

Lecture Chemotherapy including biologicals  
P. Pfeiffer, DK

  9:00

Group sessions: Making a protocol

 

Group 1 and 2
Treatment algorithm of patients with primary colorectal cancer and distant metastases
Group 3 and 4
Treatment algorithm of patients with locally advanced rectal cancer

 10:00

Plenary session: Making a protocol
Treatment algorithm of patients with primary colorectal cancer and distant metastases

 Group 2
Presentation of the first protocol
 10:30Discussion with the experts:
K. Havenga, NL - P. Pfeiffer, DK - Representative of G1

 11:00

Coffee break
 11:30

Plenary sessions: Making a protocol

 Treatment algorithm of patients with locally advanced rectal cancer
Chair: L. Påhlman, SE
 Group 3: Presetation of the second protocol
Representative of G3
 12:00Discussion with the experts
K. Havenga, NL - P. Pfeiffer, DK - G. Poston, UK - Representative of G4 
 12:30Closing remarks
T. Wiggers, NL
 13:00Airport transfers and departures